Cathie Wood’s ARK Invest Sells Over 60,000 Shares of Pluristem Therapeutics
One of Cathie Wood's Ark Invest funds sold over 62,000 shares of Pluristem Therapeutics on June 29.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 62,000 shares of Pluristem Therapeutics Inc. (NASDAQ: PSTI) on Tuesday, as the share price of this fund traded up less than 1% in the day’s session. That share price has greatly improved over the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 62,738 shares of Pluristem. At Tuesday’s closing price, this would have valued this sale at roughly $252,000. This is only a small fraction of the total holdings. This fund is up 84% over the past 52 weeks.
Here is a quick look at all the other sales that took place across all ARK ETFs:
| Fund | Ticker | Company | Shares |
|---|---|---|---|
| ARKG | CSTL | Castle Biosciences | 4,800 |
| ARKG | PSTI | Pluristem Therapeutics | 62,738 |
| ARKQ | GLEO | Galileo Acquisition | 1,798 |
| ARKQ | RAVN | Raven Industries | 8,104 |
| ARKW | LC | LendingClub | 82 |
| ARKW | PD | PagerDuty | 6,567 |
| ARKW | ROKU | Roku | 5,986 |
| ARKW | SE | Sea | 21,337 |
[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=905905][wallst_email_signup]
Contact [email protected] for any questions or corrections.







